Glutamyl endopeptidase GluV8 explained

Glutamyl endopeptidase
Ec Number:3.4.21.19
Cas Number:137010-42-5
Glutamyl endopeptidase

Glutamyl endopeptidase (SspA, V8 protease, GluV8, endoproteinase Glu-C, staphylococcal serine proteinase) is an extracellular bacterial serine protease of the glutamyl endopeptidase I family that was initially isolated from the Staphylococcus aureus strain V8. The protease is, hence, commonly referred to as "V8 protease", or alternatively SspA from its corresponding gene.[1] [2] [3]

Genetics

Glutamyl endopeptidase is in S. aureus expressed from the gene sspA within the operon ssp. Downstream of sspA, the operon also includes the genes of the cysteine protease staphopain B (sspB) and of staphostatin B (sspC; specific inhibitor of staphopain B).[4]

Glutamyl endopeptidase is largely co-expressed with the other major proteases of S. aureus: aureolysin, staphopain A, and staphopain B. The transcription of ssp, that occurs via a promoter controlled by "housekeeping" sigma factor σA, is up-regulated by accessory gene regulator agr, while it is repressed by staphylococcal accessory regulator sarA and by alternative sigma factor σB (a stress response modulator of Gram-positive bacteria). ssp expression is highly expressed in post-exponential growth phase. A more complex network of modulators and of environmental conditions affecting ssp expression have been suggested, however.[5] [6]

The sspA gene has a high prevalence in the genome of both commensal- and pathogenic-type S. aureus strains.[7]

Activation

Glutamyl endopeptidase is expressed as a zymogen that, in order to become fully active, has been modified both through autocatalysis and through cleavage by the metalloprotease aureolysin.[8] [9]

Function

Glutamyl endopeptidase proteolytically activates the zymogen of the cysteine protease staphopain B (staphopain A is activated through and independent process).[10] [11] [12]

The bacterial protease has a narrow specificity, with a strict preference for catalyzing hydrolysis of proteins after negatively charged amino acids, especially glutamic acid, and to some extent aspartic acid.[13] Aspartic acid is cleaved mainly when followed by a small amino acid, such as glycine.

Glutamyl endopeptidase has been shown to cleave certain target proteins among human inflammatory regulators and immune components. It can process kininogen into kinin, and cleave immunoglobulins. The protease also cleaves and inactivates α1-antitrypsin, but is successfully inhibited by α2-macroglubulin. Glutamyl endopeptidase can inhibit the activation of targets within the complement system. It is indicated to cause inhibition to all three pathways of complement activation.[14]

Glutamyl endopeptidase can furthermore cleave a wide array bacterial surface proteins, including fibronectin-binding proteins and protein A, potentially acting as a self-regulatory mechanism.[15] [16] [17]

Biological significance

An immunization survey of human serum samples suggests that exposure to glutamyl endopeptidase is common, although a correlation to any specific type of infection could not be established. The numerous targets of bacterial proteases, adding the complexity of other virulence factors and their genetic regulation, makes it difficult to attribute a specific role of the protease for the bacteria. In vivo trials with S. aureus with inactivation of ssp or sspA controlling glutamyl endopeptidase gives a contradictory picture for its importance, although it has shown impact for bacterial survival in human whole blood. It has been suggested, however, that the protease promotes S. aureus dissemination through cleavage of self-proteins and through kinin-induced vasodilation, simultaneously protecting against immunological responses, i.e. through corruption of the regulation of the complement system and of neutrophil-derived proteases.[18] [19]

Glutamyl endopeptidase is indicated to participate in control and dissemination in bacterial biofilms.[20]

The protease can contribute to infection symptoms, e.g. pain and edema through increased vascular permeability by activating kinin. De-regulation of neutrophil proteases through inactivation of α1-antitrypsin has been suggested as a potential cause of dysfunctional coagulation in sepsis.[21]

External links

Notes and References

  1. Dubin G . Extracellular proteases of Staphylococcus spp . Biological Chemistry . 383 . 7–8 . 1075–1086 . 2002-07-01 . 12437090 . 10.1515/BC.2002.116 . 23295763 .
  2. Book: Handbook of Proteolytic Enzymes. Stennicke. Henning R.. Breddam. Klaus. Rawlings. Neil D. . vanc . 2013-01-01. Academic Press. 9780123822192. 2534–2538. 10.1016/b978-0-12-382219-2.00561-5. Salvesen. Guy.
  3. Book: Methods in Enzymology . 244 . 1994 . Chapter 8: Glutamyl endopeptidases. Birktoft. Jens J.. Breddam. Klaus. vanc . 114–126. 10.1016/0076-6879(94)44010-7 . 7845201 . 9780121821456 .
  4. Filipek R, Rzychon M, Oleksy A, Gruca M, Dubin A, Potempa J, Bochtler M . The Staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease . The Journal of Biological Chemistry . 278 . 42 . 40959–40966 . October 2003 . 12874290 . 10.1074/jbc.M302926200 . free .
  5. Oscarsson J, Tegmark-Wisell K, Arvidson S . Coordinated and differential control of aureolysin (aur) and serine protease (sspA) transcription in Staphylococcus aureus by sarA, rot and agr (RNAIII) . International Journal of Medical Microbiology . 296 . 6 . 365–380 . October 2006 . 16782403 . 10.1016/j.ijmm.2006.02.019 .
  6. Lindsay JA, Foster SJ . Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in Staphylococcus aureus . Molecular & General Genetics . 262 . 2 . 323–331 . September 1999 . 10517329 . 10.1007/s004380051090 . 29491620 .
  7. Zdzalik M, Karim AY, Wolski K, Buda P, Wojcik K, Brueggemann S, Wojciechowski P, Eick S, Calander AM, Jonsson IM, Kubica M, Polakowska K, Miedzobrodzki J, Wladyka B, Potempa J, Dubin G . 6 . Prevalence of genes encoding extracellular proteases in Staphylococcus aureus - important targets triggering immune response in vivo . FEMS Immunology and Medical Microbiology . 66 . 2 . 220–229 . November 2012 . 22762789 . 10.1111/j.1574-695X.2012.01005.x . free .
  8. Shaw L, Golonka E, Potempa J, Foster SJ . The role and regulation of the extracellular proteases of Staphylococcus aureus . Microbiology . 150 . Pt 1 . 217–228 . January 2004 . 14702415 . 10.1099/mic.0.26634-0 . free .
  9. Nickerson NN, Prasad L, Jacob L, Delbaere LT, McGavin MJ . Activation of the SspA serine protease zymogen of Staphylococcus aureus proceeds through unique variations of a trypsinogen-like mechanism and is dependent on both autocatalytic and metalloprotease-specific processing . The Journal of Biological Chemistry . 282 . 47 . 34129–34138 . November 2007 . 17878159 . 10.1074/jbc.M705672200 . free .
  10. Nickerson N, Ip J, Passos DT, McGavin MJ . Comparison of Staphopain A (ScpA) and B (SspB) precursor activation mechanisms reveals unique secretion kinetics of proSspB (Staphopain B), and a different interaction with its cognate Staphostatin, SspC . Molecular Microbiology . 75 . 1 . 161–177 . January 2010 . 19943908 . 10.1111/j.1365-2958.2009.06974.x . free .
  11. Rice K, Peralta R, Bast D, de Azavedo J, McGavin MJ . Description of staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease . Infection and Immunity . 69 . 1 . 159–169 . January 2001 . 11119502 . 97868 . 10.1128/IAI.69.1.159-169.2001 .
  12. Massimi I, Park E, Rice K, Muller-Esterl W, Sauder D, McGavin MJ . Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus . The Journal of Biological Chemistry . 277 . 44 . 41770–41777 . November 2002 . 12207024 . 10.1074/jbc.M207162200 . free .
  13. Houmard J, Drapeau GR . Staphylococcal protease: a proteolytic enzyme specific for glutamoyl bonds . Proceedings of the National Academy of Sciences of the United States of America . 69 . 12 . 3506–3509 . December 1972 . 4509307 . 389807 . 10.1073/pnas.69.12.3506 . 1972PNAS...69.3506H . free .
  14. Jusko M, Potempa J, Kantyka T, Bielecka E, Miller HK, Kalinska M, Dubin G, Garred P, Shaw LN, Blom AM . 6 . Staphylococcal proteases aid in evasion of the human complement system . Journal of Innate Immunity . 6 . 1 . 31–46 . 2014-01-01 . 23838186 . 3972074 . 10.1159/000351458 .
  15. Karlsson A, Saravia-Otten P, Tegmark K, Morfeldt E, Arvidson S . Decreased amounts of cell wall-associated protein A and fibronectin-binding proteins in Staphylococcus aureus sarA mutants due to up-regulation of extracellular proteases . Infection and Immunity . 69 . 8 . 4742–4748 . August 2001 . 11447146 . 98560 . 10.1128/IAI.69.8.4742-4748.2001 .
  16. McGavin MJ, Zahradka C, Rice K, Scott JE . Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease . Infection and Immunity . 65 . 7 . 2621–2628 . July 1997 . 9199429 . 175371 . 10.1128/iai.65.7.2621-2628.1997 .
  17. Kolar SL, Ibarra JA, Rivera FE, Mootz JM, Davenport JE, Stevens SM, Horswill AR, Shaw LN . 6 . Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulence-determinant stability . MicrobiologyOpen . 2 . 1 . 18–34 . February 2013 . 23233325 . 3584211 . 10.1002/mbo3.55 .
  18. Potempa J, Pike RN . Corruption of innate immunity by bacterial proteases . Journal of Innate Immunity . 1 . 2 . 70–87 . 2009-01-01 . 19756242 . 2743019 . 10.1159/000181144 .
  19. Koziel J, Potempa J . Protease-armed bacteria in the skin . Cell and Tissue Research . 351 . 2 . 325–337 . February 2013 . 22358849 . 3560952 . 10.1007/s00441-012-1355-2 .
  20. Chen C, Krishnan V, Macon K, Manne K, Narayana SV, Schneewind O . Secreted proteases control autolysin-mediated biofilm growth of Staphylococcus aureus . The Journal of Biological Chemistry . 288 . 41 . 29440–29452 . October 2013 . 23970550 . 3795244 . 10.1074/jbc.M113.502039 . free .
  21. Potempa J, Watorek W, Travis J . The inactivation of human plasma alpha 1-proteinase inhibitor by proteinases from Staphylococcus aureus . The Journal of Biological Chemistry . 261 . 30 . 14330–14334 . October 1986 . 3533918 . 10.1016/S0021-9258(18)67022-X . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Glutamyl endopeptidase GluV8".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.